Adverse Events, Comorbidities, and HIV

Aug. 6, 2020: Recent trends in drug interaction rates; integrase inhibitors and cardiac event risk; a deep dive into HIV drug resistance in Florida; frailty symptoms and neurocognitive disorders amidst high CD4 counts.

An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.

Research showing housing as part of public health in HIV has long been established. But now, experts are also seeing the connection to COVID-19.

LaRon Nelson, Ph.D., RN, talks about public health’s responsibility to meet this extraordinary moment.

July 23, 2020: Depression and HIV risk mitigation among MSM; a consistent HIV provider is good for CD4 and viral load; spirituality and HIV prevention; HCV treatment access and reinfection risk.

Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.

July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?

COVID-19 or no, there was still plenty to learn at this year's virtual conference, including for U.S. clinicians seeking to improve the care and treatment they provide to their patients living with HIV.

It’s more than just HIV, but comprehensive care systems aren’t as available as they should be.

Global health leaders warn that the pandemic may impact health systems and worsen the world's pre-existing epidemics.